Provided by Tiger Trade Technology Pte. Ltd.

Lexicon Pharmaceuticals

2.25
-0.0400-1.75%
Volume:6.65M
Turnover:14.91M
Market Cap:999.00M
PE:-14.17
High:2.29
Open:2.27
Low:2.19
Close:2.29
52wk High:2.68
52wk Low:1.03
Shares:444.00M
Float Shares:220.42M
Volume Ratio:3.70
T/O Rate:3.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1587
EPS(LYR):-0.1387
ROE:-40.21%
ROA:-14.32%
PB:5.72
PE(LYR):-16.23

Loading ...

Lexicon enters USD 100 million loan facility with Hercules Capital

Reuters
·
May 07

Lexicon Pharmaceuticals Inc expected to post a loss of 3 cents a share - Earnings Preview

Reuters
·
May 05

Lexicon Pharmaceuticals : Loan Facility Provides for an Initial Interest-Only Period of 18 Months, With Potential for Two Six-Month Extensions

THOMSON REUTERS
·
May 05

Lexicon Pharmaceuticals Announces $100 Million Loan Facility With Hercules Capital

THOMSON REUTERS
·
May 05

Lexicon Pharmaceuticals: Under Terms, Initial $55 Mln Tranche Will Be Used to Repay Existing Loan Facility With Oxford Finance

THOMSON REUTERS
·
May 05

Press Release: Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital

Dow Jones
·
May 05

Lexicon Pharmaceuticals shareholders approved increase in authorized common shares to 900 million

Reuters
·
May 01

Lexicon Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026

GlobeNewswire
·
Apr 30

Lexicon says Phase 2b data support pilavapadin 10 mg for Phase 3 DPNP trial

Reuters
·
Apr 17

Lexicon to present Phase 3 SCORED and SOTA-P-CARDIA sotagliflozin data at ACC 2026

Reuters
·
Mar 24

Lexicon Pharma Price Target Maintained With a $6.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 23

Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE) and Lexicon Pharmaceuticals (LXRX)

TIPRANKS
·
Mar 23

Lexicon, Novo Nordisk announce initiation of LX9851 study

TIPRANKS
·
Mar 23

Novo Nordisk initiates Phase 1 trial of Lexicon-licensed obesity candidate LX9851

Reuters
·
Mar 23

Lexicon Pharmaceuticals Inc - Phase 1 Study of Lx9851 Expected to Complete in Q1 2027

THOMSON REUTERS
·
Mar 23

Lexicon Pharmaceuticals and Novo Nordisk Announce Initiation of Phase 1 Study With Oral Obesity Drug Candidate Lx9851

THOMSON REUTERS
·
Mar 23

Lexicon Pharmaceuticals Inc - Earns Second $10 Mln Milestone; Eligible for up to $1 Bln in Payments

THOMSON REUTERS
·
Mar 23

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Rapid Micro Biosystems (RPID), Lexicon Pharmaceuticals (LXRX) and Whitehawk Therapeutics (WHWK)

TIPRANKS
·
Mar 13

Lexicon announces results from post hoc analysis on data of sotagliflozin

TIPRANKS
·
Mar 11

Lexicon to present sotagliflozin kidney function analysis at ATTD conference

Reuters
·
Mar 11